BLRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biolinerx Ltd (BLRX).


$17.11M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

BLRX Market Cap. (MRY)


BLRX Shares Outstanding (MRY)


BLRX Assets (MRY)


Total Assets

$38.91M

Total Liabilities

$25.45M

Total Investments

$0

BLRX Income (MRY)


Revenue

$28.94M

Net Income

-$9.22M

Operating Expense

$40.09M

BLRX Cash Flow (MRY)


CF Operations

-$43.87M

CF Investing

$29.37M

CF Financing

$20.66M

BLRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BLRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$38,906,000 (-39.14%)

$63,925,000 (-16.31%)

$76,384,000 (-6.15%)

$81,391,000 (72.11%)

Assets Current

$27,104,000 (-42.56%)

$47,183,000 (-9.27%)

$52,001,000 (-9.41%)

$57,404,000 (150.89%)

Assets Non-Current

$11,802,000 (-29.51%)

$16,742,000 (-31.34%)

$24,383,000 (1.65%)

$23,987,000 (-1.73%)

Goodwill & Intangible Assets

$10,449,000 (-29.66%)

$14,854,000 (-32.13%)

$21,885,000 (0.83%)

$21,704,000 (-0.05%)

Shareholders Equity

$13,461,000 (1.80%)

$13,223,000 (-73.99%)

$50,841,000 (-25.33%)

$68,087,000 (209.06%)

Property Plant & Equipment Net

$1,353,000 (-28.34%)

$1,888,000 (-24.42%)

$2,498,000 (9.42%)

$2,283,000 (-15.32%)

Cash & Equivalents

$19,562,000 (-54.50%)

$42,994,000 (-15.83%)

$51,082,000 (-10.59%)

$57,135,000 (152.96%)

Accumulated Other Comprehensive Income

-$1,416,000 (0.00%)

-$1,416,000 (0.00%)

-$1,416,000 (0.00%)

-$1,416,000 (0.00%)

Deferred Revenue

$0 (0%)

$12,957,000 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$3,145,000 (61.03%)

$1,953,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,954,000 (232.83%)

$1,188,000 (64.77%)

$721,000 (407.75%)

$142,000 (0.71%)

Trade & Non-Trade Payables

$5,583,000 (-48.63%)

$10,869,000 (56.03%)

$6,966,000 (25.13%)

$5,567,000 (-5.93%)

Accumulated Retained Earnings (Deficit)

-$399,827,000 (-2.36%)

-$390,606,000 (-18.37%)

-$329,992,000 (-8.18%)

-$305,041,000 (-9.73%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$15,040,000 (29.76%)

$11,591,000 (-5.95%)

$12,324,000 (164.98%)

$4,651,000 (-39.47%)

Debt Current

$5,001,000 (36.16%)

$3,673,000 (86.54%)

$1,969,000 (-32.68%)

$2,925,000 (-10.90%)

Debt Non-Current

$10,039,000 (26.79%)

$7,918,000 (-23.53%)

$10,355,000 (499.94%)

$1,726,000 (-60.78%)

Total Liabilities

$25,445,000 (-49.81%)

$50,702,000 (98.50%)

$25,543,000 (91.99%)

$13,304,000 (-47.33%)

Liabilities Current

$15,406,000 (-50.06%)

$30,852,000 (188.90%)

$10,679,000 (9.88%)

$9,719,000 (-8.66%)

Liabilities Non-Current

$10,039,000 (-49.43%)

$19,850,000 (33.54%)

$14,864,000 (314.62%)

$3,585,000 (-75.48%)

BLRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$28,940,000 (502.92%)

$4,800,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$9,263,000 (150.89%)

$3,692,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$29,926,000 (-5.24%)

$31,580,000 (173.94%)

$11,528,000 (117.06%)

$5,311,000 (11.72%)

Research & Development Expense

$9,149,000 (-26.92%)

$12,519,000 (-28.99%)

$17,629,000 (-9.44%)

$19,466,000 (7.11%)

Operating Expenses

$40,085,000 (-21.10%)

$50,802,000 (74.24%)

$29,157,000 (17.68%)

$24,777,000 (8.07%)

Interest Expense

$9,119,000 (320.42%)

$2,169,000 (0.51%)

$2,158,000 (114.51%)

$1,006,000 (-38.24%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$9,221,000 (84.79%)

-$60,614,000 (-142.93%)

-$24,951,000 (7.77%)

-$27,054,000 (9.88%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$9,221,000 (84.79%)

-$60,614,000 (-142.93%)

-$24,951,000 (7.77%)

-$27,054,000 (9.88%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$9,221,000 (84.79%)

-$60,614,000 (-142.93%)

-$24,951,000 (7.77%)

-$27,054,000 (9.88%)

Weighted Average Shares

$1,198,107,761 (24.37%)

$963,365,525 (24.47%)

$773,956,973 (16.75%)

$662,933,695 (162.19%)

Weighted Average Shares Diluted

$1,198,107,761 (24.37%)

$963,365,525 (24.47%)

$773,956,973 (16.75%)

$662,933,695 (162.19%)

Earning Before Interest & Taxes (EBIT)

-$102,000 (99.83%)

-$58,445,000 (-156.42%)

-$22,793,000 (12.50%)

-$26,048,000 (8.26%)

Gross Profit

$19,677,000 (1675.90%)

$1,108,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$20,408,000 (58.93%)

-$49,694,000 (-70.44%)

-$29,157,000 (-17.68%)

-$24,777,000 (-8.07%)

BLRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$29,374,000 (1934.21%)

$1,444,000 (-63.95%)

$4,006,000 (110.48%)

-$38,224,000 (-329.33%)

Net Cash Flow from Financing

$20,658,000 (37.21%)

$15,056,000 (-26.33%)

$20,438,000 (-64.61%)

$57,749,000 (223.23%)

Net Cash Flow from Operations

-$43,873,000 (-94.06%)

-$22,608,000 (13.84%)

-$26,240,000 (-11.31%)

-$23,573,000 (-1.58%)

Net Cash Flow / Change in Cash & Cash Equivalents

$6,159,000 (200.83%)

-$6,108,000 (-240.09%)

-$1,796,000 (55.63%)

-$4,048,000 (-135.73%)

Net Cash Flow - Business Acquisitions and Disposals

-

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$29,428,000 (1590.29%)

$1,741,000 (-59.72%)

$4,322,000 (111.34%)

-$38,127,000 (-328.74%)

Capital Expenditure

-$53,000 (54.31%)

-$116,000 (11.45%)

-$131,000 (-35.05%)

-$97,000 (0%)

Issuance (Repayment) of Debt Securities

$4,279,000 (315.24%)

-$1,988,000 (-132.73%)

$6,074,000 (270.04%)

-$3,572,000 (-6.40%)

Issuance (Purchase) of Equity Shares

$16,379,000 (16.03%)

$14,116,000 (-1.73%)

$14,364,000 (-71.51%)

$50,414,000 (161.84%)

Payment of Dividends & Other Cash Distributions

-

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$22,000 (109.82%)

-$224,000 (63.10%)

-$607,000 (-393.24%)

$207,000 (0.49%)

Share Based Compensation

$1,135,000 (-51.10%)

$2,321,000 (3.39%)

$2,245,000 (50.17%)

$1,495,000 (17.53%)

Depreciation Amortization & Accretion

$4,065,000 (193.71%)

$1,384,000 (111.62%)

$654,000 (-6.97%)

$703,000 (-24.73%)

BLRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

68.00% (194.37%)

23.10%

-

-

Profit Margin

-31.90% (97.47%)

-1262.80%

-

-

EBITDA Margin

13.70% (101.15%)

-1188.80%

-

-

Return on Average Equity (ROAE)

-75.30% (73.13%)

-280.20% (-535.37%)

-44.10% (-13.08%)

-39.00% (66.03%)

Return on Average Assets (ROAA)

-17.70% (82.16%)

-99.20% (-198.80%)

-33.20% (-5.40%)

-31.50% (49.28%)

Return on Sales (ROS)

-0.40% (99.97%)

-1217.60%

-

-

Return on Invested Capital (ROIC)

-1.70% (-100.00%)

77667.80% (3078.17%)

-2607.90% (-190.01%)

2897.40% (221.08%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-856 (-3171.30%)

-26.17 (-33.05%)

-19.67 (61.44%)

-51 (-142.86%)

Price to Sales Ratio (P/S)

0.59 (-97.19%)

21.01

-

-

Price to Book Ratio (P/B)

1.27 (-82.72%)

7.35 (929.97%)

0.71 (-49.61%)

1.42 (-37.33%)

Debt to Equity Ratio (D/E)

1.89 (-50.70%)

3.83 (663.75%)

0.5 (157.44%)

0.2 (-83.00%)

Earnings Per Share (EPS)

-0.01 (83.33%)

-0.06 (-100.00%)

-0.03 (25.00%)

-0.04 (66.67%)

Sales Per Share (SPS)

14.49 (19224.00%)

0.07 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-22 (-6114.12%)

-0.35 (30.72%)

-0.51 (4.66%)

-0.54 (61.07%)

Book Value Per Share (BVPS)

6.74 (3172.33%)

0.21 (-79.09%)

0.98 (-36.08%)

1.54 (17.90%)

Tangible Assets Book Value Per Share (TABVPS)

14.25 (1765.31%)

0.76 (-27.65%)

1.06 (-21.78%)

1.35 (-11.01%)

Enterprise Value Over EBIT (EV/EBIT)

-172 (-17100.00%)

-1 (0%)

0 (0%)

-2 (-100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

4.43 (398.85%)

-1.48 (-423.58%)

0.46 (129.27%)

-1.56 (-15.16%)

Asset Turnover

0.56 (605.06%)

0.08 (0%)

0 (0%)

0 (0%)

Current Ratio

1.76 (15.04%)

1.53 (-68.60%)

4.87 (-17.56%)

5.91 (174.70%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$43,926,000 (-93.30%)

-$22,724,000 (13.83%)

-$26,371,000 (-11.41%)

-$23,670,000 (-2.00%)

Enterprise Value (EV)

$17,553,699 (-79.25%)

$84,591,331 (933.60%)

-$10,147,735 (-125.59%)

$39,662,292 (6.30%)

Earnings Before Tax (EBT)

-$9,221,000 (84.79%)

-$60,614,000 (-142.93%)

-$24,951,000 (7.77%)

-$27,054,000 (9.88%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$3,963,000 (106.95%)

-$57,061,000 (-157.74%)

-$22,139,000 (12.65%)

-$25,345,000 (7.70%)

Invested Capital

$8,529,000 (164.69%)

-$13,184,000 (-360.45%)

$5,062,000 (301.19%)

-$2,516,000 (-7962.50%)

Working Capital

$11,698,000 (-28.37%)

$16,331,000 (-60.48%)

$41,322,000 (-13.34%)

$47,685,000 (289.62%)

Tangible Asset Value

$28,457,000 (-42.01%)

$49,071,000 (-9.96%)

$54,499,000 (-8.69%)

$59,687,000 (133.37%)

Market Capitalization

$17,112,699 (-82.40%)

$97,246,331 (167.89%)

$36,301,265 (-62.36%)

$96,445,292 (93.60%)

Average Equity

$12,251,750 (-43.36%)

$21,631,250 (-61.77%)

$56,586,500 (-18.44%)

$69,382,000 (165.38%)

Average Assets

$51,961,000 (-14.94%)

$61,090,500 (-18.73%)

$75,167,000 (-12.40%)

$85,806,000 (77.39%)

Invested Capital Average

$6,066,750 (8162.13%)

-$75,250 (-108.61%)

$874,000 (197.22%)

-$899,000 (-175.77%)

Shares

1,199,485,845 (29.11%)

929,058,619 (0.67%)

922,867,375 (30.14%)

709,121,103 (139.16%)